The role of IL-6 in pathogenesis of abdominal aortic aneurysm in mice

PLoS ONE

Volumn 12, Issue 10, 2017, Pages

  Nishihara, Michihide ^a   Aoki, Hiroki ^b   Ohno, Satoko ^a   Furusho, Aya ^a   Hirakata, Saki ^a   Nishida, Norifumi ^a   Ito, Sohei ^a   Hayashi, Makiko ^a   Imaizumi, Tsutomu ^c   Fukumoto, Yoshihiro ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY   (Japan)

^c INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALCIUM CHLORIDE; CHEMOKINE; GAMMA INTERFERON; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MR16 1; MONOCYTE CHEMOTACTIC PROTEIN 1; SMAD2 PROTEIN; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; INTERLEUKIN 6 RECEPTOR; NEUTRALIZING ANTIBODY; TRANSCRIPTOME;

ABDOMINAL AORTIC ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; C57BL 6 MOUSE; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MOLECULAR PATHOLOGY; MORPHOMETRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; ANIMAL; DISEASE MODEL; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; AORTIC ANEURYSM, ABDOMINAL; DISEASE MODELS, ANIMAL; INTERLEUKIN-6; MICE; RECEPTORS, INTERLEUKIN-6; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 85030763088     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0185923     Document Type: Article

References (37)

1. Cronenwett JL, Johnston KW. 8th ed. Philadelphia: Elsevier Health Sciences; 2014.
2. Aoki H, Yoshimura K, Matsuzaki M. Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy. J Mol Med. 2007; 85(10):1077–88. https://doi.org/10.1007/s00109-007-0213-2 PMID: 17522832.
3. Senemaud J, Caligiuri G, Etienne H, Delbosc S, Michel JB, Coscas R. Translational Relevance and Recent Advances of Animal Models of Abdominal Aortic Aneurysm. Arterioscler Thromb Vasc Biol. 2017. https://doi.org/10.1161/ATVBAHA.116.308534 PMID: 28062500.
4. Wang Y, Krishna S, Golledge J. The calcium chloride-induced rodent model of abdominal aortic aneurysm. Atherosclerosis. 2013; 226(1):29–39. Epub 2012/10/10. https://doi.org/10.1016/j.atherosclerosis.2012.09.010 PMID: 23044097.
5. Yoshimura K, Aoki H, Ikeda Y, Fujii K, Akiyama N, Furutani A, et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med. 2005; 11(12):1330–8. https://doi.org/10.1038/nm1335 PMID: 16311603.
6. Miyake T, Aoki M, Masaki H, Kawasaki T, Oishi M, Kataoka K, et al. Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit model. Circ Res. 2007; 101(11):1175–84. Epub 2007/09/22. CIRCRESAHA.107.148668 [pii] https://doi.org/10.1161/CIRCRESAHA.107.148668 PMID: 17885220.
7. Emeto TI, Seto SW, Golledge J. Targets for medical therapy to limit abdominal aortic aneurysm progression. Curr Drug Targets. 2014; 15(9):860–73. PMID: 25090988.
8. Timlin H, Bingham CO 3rd. Efficacy and safety implications of molecular constructs of biological agents for rheumatoid arthritis. Expert Opin Biol Ther. 2014; 14(7):893–904. https://doi.org/10.1517/14712598.2014.900536 PMID: 24720727.
9. Hingorani A, Ascher E, Scheinman M, Yorkovich W, DePippo P, Ladoulis CT, et al. The effect of tumor necrosis factor binding protein and interleukin-1 receptor antagonist on the development of abdominal aortic aneurysms in a rat model. J Vasc Surg. 1998; 28(3):522–6. PMID: 9737463.
10. Xiong W, MacTaggart J, Knispel R, Worth J, Persidsky Y, Baxter BT. Blocking TNF-alpha attenuates aneurysm formation in a murine model. J Immunol. 2009; 183(4):2741–6. Epub 2009/07/22. jimmunol.0803164 [pii] https://doi.org/10.4049/jimmunol.0803164 PMID: 19620291.
11. Johnston WF, Salmon M, Su G, Lu G, Stone ML, Zhao Y, et al. Genetic and pharmacologic disruption of interleukin-1beta signaling inhibits experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol. 2013; 33(2):294–304. Epub 2013/01/05. https://doi.org/10.1161/ATVBAHA.112.300432 PMID: 23288154; PubMed Central PMCID: PMC3632435.
12. Ijaz T, Tilton RG, Brasier AR. Cytokine amplification and macrophage effector functions in aortic inflammation and abdominal aortic aneurysm formation. J Thorac Dis. 2016; 8(8):E746–54. https://doi.org/10.21037/jtd.2016.06.37 PMID: 27619163; PubMed Central PMCID: PMCPMC4999690.
13. Shteinberg D, Halak M, Shapiro S, Kinarty A, Sobol E, Lahat N, et al. Abdominal aortic aneurysm and aortic occlusive disease: a comparison of risk factors and inflammatory response. Eur J Vasc Endovasc Surg. 2000; 20(5):462–5. https://doi.org/10.1053/ejvs.2000.1210 PMID: 11112466.
14. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A. 1993; 90(24):11924–8. PMID: 8265649; PubMed Central PMCID: PMCPMC48097.
15. Aoki H, Ohno S, Furusho A, Nishihara M, Nishida N, Hirakata S, et al. Mouse Model of Abdominal Aortic Aneurysm Induced by CaCl2. In: Sata M, editor. Mouse Models of Vascular Diseases: Springer Japan; 2016. p. 211–26.
16. Yoshida H, Hashizume M, Suzuki M, Mihara M. Induction of high-dose tolerance to the rat anti-mouse IL-6 receptor antibody in NZB/NZW F1 mice. Rheumatol Int. 2011; 31(11):1445–9. https://doi.org/10.1007/s00296-010-1500-8 PMID: 20473503.
17. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44–57. Epub 2009/01/10. nprot.2008.211 [pii] https://doi.org/10.1038/nprot.2008.211 PMID: 19131956.
18. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002; 110(5):625–32. https://doi.org/10.1172/JCI15334 PMID: 12208863
19. Ishibashi M, Egashira K, Zhao Q, Hiasa K, Ohtani K, Ihara Y, et al. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol. 2004; 24(11): e174–8. https://doi.org/10.1161/01.ATV.0000143384.69170.2d PMID: 15331433.
20. Moehle CW, Bhamidipati CM, Alexander MR, Mehta GS, Irvine JN, Salmon M, et al. Bone marrow-derived MCP1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation. J Thorac Cardiovasc Surg. 2011. Epub 2011/10/15. S0022-5223(11)00829-4 [pii] https://doi.org/10.1016/j.jtcvs.2011.07.053 PMID: 21996300.
21. Henaut L, Sanchez-Nino MD, Aldamiz-Echevarria Castillo G, Sanz AB, Ortiz A. Targeting local vascular and systemic consequences of inflammation on vascular and cardiac valve calcification. Expert Opin Ther Targets. 2016; 20(1):89–105. https://doi.org/10.1517/14728222.2015.1081685 PMID: 26788590.
22. Kimura T, Shiraishi K, Furusho A, Ito S, Hirakata S, Nishida N, et al. Tenascin C protects aorta from acute dissection in mice. Sci Rep. 2014; 4:4051. https://doi.org/10.1038/srep04051 PMID: 24514259; PubMed Central PMCID: PMCPMC3920275.
23. Mihara M, Nishimoto N, Yoshizaki K, Suzuki T. Influences of anti-mouse interleukin-6 receptor antibody on immune responses in mice. Immunol Lett. 2002; 84(3):223–9. PMID: 12413741.
24. Bobik A. Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol. 2006; 26(8):1712–20. Epub 2006/05/06. https://doi.org/10.1161/01.ATV.0000225287.20034.2c PMID: 16675726.
25. Chen X, Rateri DL, Howatt DA, Balakrishnan A, Moorleghen JJ, Cassis LA, et al. TGF-beta Neutralization Enhances AngII-Induced Aortic Rupture and Aneurysm in Both Thoracic and Abdominal Regions. PLoS One. 2016; 11(4):e0153811. https://doi.org/10.1371/journal.pone.0153811 PMID: 27104863; PubMed Central PMCID: PMCPMC4841552.
26. Hartman MH, Vreeswijk-Baudoin I, Groot HE, van de Kolk KW, de Boer RA, Mateo Leach I, et al. Inhibition of Interleukin-6 Receptor in a Murine Model of Myocardial Ischemia-Reperfusion. PLoS One. 2016; 11(12):e0167195. https://doi.org/10.1371/journal.pone.0167195 PMID: 27936014; PubMed Central PMCID: PMCPMC5147868.
27. Niida T, Isoda K, Kitagaki M, Ishigami N, Adachi T, Matsubara O, et al. IkappaBNS regulates interleukin-6 production and inhibits neointimal formation after vascular injury in mice. Cardiovasc Res. 2012; 93(2):371–9. https://doi.org/10.1093/cvr/cvr323 PMID: 22135163.
28. Hashimoto-Kataoka T, Hosen N, Sonobe T, Arita Y, Yasui T, Masaki T, et al. Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension. Proc Natl Acad Sci U S A. 2015; 112(20):E2677–86. https://doi.org/10.1073/pnas.1424774112 PMID: 25941359; PubMed Central PMCID: PMCPMC4443312.
29. Sporri B, Muller KM, Wiesmann U, Bickel M. Soluble IL-6 receptor induces calcium flux and selectively modulates chemokine expression in human dermal fibroblasts. Int Immunol. 1999; 11(7):1053–8. PMID: 10383937.
30. Qu T, Yang H, Walston JD, Fedarko NS, Leng SX. Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailty. Cytokine. 2009; 46(3):319–24. https://doi.org/10.1016/j.cyto.2009.02.015 PMID: 19342252; PubMed Central PMCID: PMCPMC3159181.
31. Yoshizaki T, Sato H, Furukawa M, Pagano JS. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc Natl Acad Sci U S A. 1998; 95 (7):3621–6. PMID: 9520415; PubMed Central PMCID: PMCPMC19885.
32. Araki Y, Tsuzuki Wada T, Aizaki Y, Sato K, Yokota K, Fujimoto K, et al. Histone Methylation and STAT-3 Differentially Regulate Interleukin-6-Induced Matrix Metalloproteinase Gene Activation in Rheumatoid Arthritis Synovial Fibroblasts. Arthritis Rheumatol. 2016; 68(5):1111–23. https://doi.org/10.1002/art.39563 PMID: 26713842.
33. Ma Z, Qin H, Benveniste EN. Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J Immunol. 2001; 167(9):5150–9. PMID: 11673527.
34. Rabkin SW. The Role Matrix Metalloproteinases in the Production of Aortic Aneurysm. Prog Mol Biol Transl Sci. 2017; 147:239–65. https://doi.org/10.1016/bs.pmbts.2017.02.002 PMID: 28413030.
35. Nagahama KY, Togo S, Holz O, Magnussen H, Liu X, Seyama K, et al. Oncostatin M modulates fibroblast function via signal transducers and activators of transcription proteins-3. Am J Respir Cell Mol Biol. 2013; 49(4):582–91. https://doi.org/10.1165/rcmb.2012-0460OC PMID: 23668543.
36. Arnaoutoglou E, Kouvelos G, Koutsoumpelis A, Patelis N, Lazaris A, Matsagkas M. An Update on the Inflammatory Response after Endovascular Repair for Abdominal Aortic Aneurysm. Mediators Inflamm. 2015; 2015:945035. https://doi.org/10.1155/2015/945035 PMID: 26166953; PubMed Central PMCID: PMCPMC4488540.
37. Harrison SC, Smith AJ, Jones GT, Swerdlow DI, Rampuri R, Bown MJ, et al. Interleukin-6 receptor pathways in abdominal aortic aneurysm. Eur Heart J. 2013; 34(48):3707–16. https://doi.org/10.1093/eurheartj/ehs354 PMID: 23111417; PubMed Central PMCID: PMCPMC3869968.